The effect of clinical trials on treatment in myocardial infarction

被引：0
|
作者：
Wilhelmsen, L [1 ]
机构：
[1] Univ Gothenburg, Sect Prevent Cardiol, Gothenburg, Sweden
来源：
JOURNAL OF INTERNAL MEDICINE | 1999年 / 245卷 / 01期
关键词：
D O I：
10.1046/j.1365-2796.1999.00431.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [41] A Snapshot on Clinical Trials on Zotarolimus DES: A Repurposing Drug against Myocardial Infarction
    Undale, Vaishali R.
    Lembhe, Shweta K.
    Satone, Shital D.
    Hase, Pratiksha
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2025, 34 (01) : 23 - 32
  • [42] Therapy of acute myocardial infarction, impact of clinical trials on clinical practice: The MITRA pilot phase
    Schuster, S
    Koch, A
    Burczyk, U
    Schiele, R
    Wagner, S
    Zahn, R
    Glunz, HG
    Heinrich, F
    Stuby, K
    Berg, G
    Voigtlander, T
    Gieseler, U
    Jakob, M
    Hauptmann, P
    Senges, J
    ZEITSCHRIFT FUR KARDIOLOGIE, 1997, 86 (04): : 273 - 283
  • [43] SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION - IMPACT OF CLINICAL-TRIALS ON CLINICAL-PRACTICE
    RUMBOLDT, Z
    BOZIC, I
    SARDELIC, S
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (3-4) : 311 - 312
  • [44] Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction
    Kim, Sang Hyun
    Shin, Sanghoon
    Choo, Eun Ho
    Choi, Ik Jun
    Lim, Sungmin
    Moon, Donggyu
    Kim, Chan Joon
    Park, Mahn-Won
    Kim, Min Chul
    Hwang, Byung-Hee
    Lee, Kwan Yong
    Choi, Yun Seok
    Kim, Hee-Yeol
    Yoo, Ki-Dong
    Jeon, Doo Soo
    Ahn, Youngkeun
    Chang, Kiyuk
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (12) : 1152 - 1161
  • [45] Clinical Impact of Dyspnea After Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients With Myocardial Infarction
    Kim, Sang Hyun
    Choo, Eun Ho
    Seo, Suk Min
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B5 - B5
  • [46] Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials
    Sykes, Robert
    Briscoe, Michael
    Krysztofiak, Thomas
    Peck, Oliver
    Mangion, Kenneth
    Berry, Colin
    OPEN HEART, 2021, 8 (01):
  • [47] HEMODEZ EFFECT IN THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    MARSHUTINA, NV
    SOVETSKAYA MEDITSINA, 1982, (05): : 30 - 34
  • [48] EFFECT OF ALLOPURINOL IN TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    NISHIMURA, N
    YAMAMOTO, Y
    TAKANO, T
    CIRCULATORY SHOCK, 1978, 5 (02) : 215 - 216
  • [49] Beta blocker treatment for acute myocardial infarction in patients with clinical evidence of heart failure: Evidence from the GUSTO trials
    Yamada, DM
    Brener, SJ
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 376A - 377A
  • [50] ADVANTAGES OF METAANALYSIS OF RANDOMIZED CONTROL TRIALS OF TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    LAU, J
    SILVA, J
    ANTMAN, E
    CHALMERS, TC
    CLINICAL RESEARCH, 1991, 39 (02): : A252 - A252
12345